{"id":"W3198710304","doi":"10.1186/s12885-021-08453-9","title":"Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study","year":2021,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"National Center for Advancing Translational Sciences; Karyopharm Therapeutics","keywords":"Medicine; Multiple myeloma; Clinical endpoint; Confidence interval; Internal medicine; Minimal clinically important difference; Quality of life (healthcare); Refractory (planetary science); Oncology; Post-hoc analysis; Clinical trial; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002281719,0.0002767579,0.0008750109,0.0001102774,0.00006366637,0.00001137845,0.0001310201,0.00007470974,0.0001661325],"category_scores_gemma":[0.001081574,0.0001584101,0.0001682577,0.0005076076,0.0001201576,0.00008255924,0.00005641048,0.0001285235,0.00000539538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004113566,"about_ca_system_score_gemma":0.001083185,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03375228,"about_ca_topic_score_gemma":0.06117009,"domain_scores_codex":[0.996899,0.000466792,0.0008884532,0.0005491858,0.0008715038,0.0003250775],"domain_scores_gemma":[0.996915,0.0009356449,0.0004094584,0.0009587284,0.0005525635,0.0002286401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0243641,0.01464076,0.9426525,0.00005361829,0.001064228,0.00004351634,0.002150354,0.00005642981,0.001551027,5.019902e-7,0.0001244553,0.01329849],"study_design_scores_gemma":[0.07211033,0.002594897,0.9176095,0.0001234252,0.0002240307,2.724287e-7,0.002097446,0.0001328743,0.004639985,0.000001241129,0.0003349286,0.0001310255],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942917,0.002053813,0.00001285305,0.0001111354,0.00007573018,0.001401852,0.001955213,0.00001767445,0.00007999581],"genre_scores_gemma":[0.9981777,0.000174659,0.0005021692,0.00004098766,0.0001236335,0.0001957136,0.0005632667,0.00002863984,0.0001932043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04774623,"threshold_uncertainty_score":0.9726821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1444107409032521,"score_gpt":0.4286966444464539,"score_spread":0.2842859035432018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}